Terms: = Lung cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Prognosis
25 results:
1. cdk6 is a novel predictive and prognosis biomarker correlated with immune infiltrates in multiple human neoplasms, including small cell lung carcinoma.
Li GS; Huang ZG; Li DM; Tang YL; Zheng JH; Yang L; Feng Y; Peng JX; Li JX; Tang YX; Zeng NY; Jin MH; Tian J; Liu J; Zhou HF; Chen G; Chen F
Funct Integr Genomics; 2023 Nov; 23(4):332. PubMed ID: 37950078
[TBL] [Abstract] [Full Text] [Related]
2. Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer.
Bai Y; Zhou L; Zhang C; Guo M; Xia L; Tang Z; Liu Y; Deng S
Oncogene; 2023 Dec; 42(49):3605-3618. PubMed ID: 37864031
[TBL] [Abstract] [Full Text] [Related]
3. SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy.
Zheng X; Lin J; Xiong J; Guan Y; Lan B; Li Y; Gao X; Fei Z; Chen L; Chen L; Chen L; Chen G; Guo Z; Yi X; Cao W; Ai X; Zhou C; Li X; Zhao J; Yan X; Yu Q; Si L; Chen Y; Chen C
BMC Cancer; 2023 Jul; 23(1):686. PubMed ID: 37479966
[TBL] [Abstract] [Full Text] [Related]
4. Pharmacological inhibition of EZH2 by ZLD1039 suppresses tumor growth and pulmonary metastasis in melanoma cells in vitro and in vivo.
Zhu Y; Zhang L; Song X; Zhang Q; Wang T; Xiao H; Yu L
Biochem Pharmacol; 2023 Apr; 210():115493. PubMed ID: 36898415
[TBL] [Abstract] [Full Text] [Related]
5. GPR37 promotes cancer growth by binding to cdk6 and represents a new theranostic target in lung adenocarcinoma.
Xie X; Cai X; Zhou F; Li Y; Liu Q; Cai L; Zhu W; Wei J; Jin C; Liu Z; Jiang C; Zhao H; Yang L; Zhao C; Huang X
Pharmacol Res; 2022 Sep; 183():106389. PubMed ID: 35934193
[TBL] [Abstract] [Full Text] [Related]
6. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract] [Full Text] [Related]
7. Oncogenic circRNA C190 Promotes Non-Small Cell lung cancer via Modulation of the EGFR/ERK Pathway.
Ishola AA; Chien CS; Yang YP; Chien Y; Yarmishyn AA; Tsai PH; Chen JC; Hsu PK; Luo YH; Chen YM; Liang KH; Lan YT; Huo TI; Ma HI; Chen MT; Wang ML; Chiou SH
Cancer Res; 2022 Jan; 82(1):75-89. PubMed ID: 34753774
[TBL] [Abstract] [Full Text] [Related]
8. Smoking status combined with tumor mutational burden as a prognosis predictor for combination immune checkpoint inhibitor therapy in non-small cell lung cancer.
Sun LY; Cen WJ; Tang WT; Long YK; Yang XH; Ji XM; Yang JJ; Zhang RJ; Wang F; Shao JY; Du ZM
Cancer Med; 2021 Oct; 10(19):6610-6617. PubMed ID: 34469045
[TBL] [Abstract] [Full Text] [Related]
9. lung adenocarcinoma with ERBB2 exon 20 insertions: Comutations and immunogenomic features related to chemoimmunotherapy.
Tian P; Zeng H; Ji L; Ding Z; Ren L; Gao W; Fan Z; Li L; Le X; Li P; Zhang M; Xia X; Zhang J; Li Y; Li W
Lung Cancer; 2021 Oct; 160():50-58. PubMed ID: 34403912
[TBL] [Abstract] [Full Text] [Related]
10. Association of Cerebrospinal Fluid Tumor DNA Genotyping With Survival Among Patients With lung Adenocarcinoma and Central Nervous System Metastases.
Li YS; Zheng MM; Jiang BY; Tu HY; Yang JJ; Zhang XC; Wu YL
JAMA Netw Open; 2020 Aug; 3(8):e209077. PubMed ID: 32749467
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy.
Wang Q; Li M; Yang M; Yang Y; Song F; Zhang W; Li X; Chen K
Aging (Albany NY); 2020 Feb; 12(4):3312-3339. PubMed ID: 32091408
[TBL] [Abstract] [Full Text] [Related]
12. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA OIP5-AS1 promotes proliferation of lung cancer cells and leads to poor prognosis by targeting miR-378a-3p.
Wang M; Sun X; Yang Y; Jiao W
Thorac Cancer; 2018 Aug; 9(8):939-949. PubMed ID: 29897167
[TBL] [Abstract] [Full Text] [Related]
14. RSK1 promotes murine breast cancer growth and metastasis.
Czaplinska D; Gorska M; Mieczkowski K; Peszynska-Sularz G; Zaczek AJ; Romanska HM; Sadej R
Folia Histochem Cytobiol; 2018; 56(1):11-20. PubMed ID: 29498411
[TBL] [Abstract] [Full Text] [Related]
15. TNFAIP8 regulates Hippo pathway through interacting with LATS1 to promote cell proliferation and invasion in lung cancer.
Han Y; Tang Z; Zhao Y; Li Q; Wang E
Mol Carcinog; 2018 Feb; 57(2):159-166. PubMed ID: 28926138
[TBL] [Abstract] [Full Text] [Related]
16. miR-218 suppresses gastric cancer cell cycle progression through the cdk6/Cyclin D1/E2F1 axis in a feedback loop.
Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
[TBL] [Abstract] [Full Text] [Related]
17. The clinicopathological and prognostic features of Chinese and Japanese inpatients with lung cancer.
Gao Y; Zhang JF; Li QC; Liu JJ; Liu LL; Yang XF; Jiang HM; Zheng HC
Oncotarget; 2016 Oct; 7(41):67425-67434. PubMed ID: 27608841
[TBL] [Abstract] [Full Text] [Related]
18. Lentivirus-mediated knockdown of TSP50 suppresses the growth of non-small cell lung cancer cells via G0/G1 phase arrest.
Qiao WL; Hu HY; Shi BW; Zang LJ; Jin W; Lin Q
Oncol Rep; 2016 Jun; 35(6):3409-18. PubMed ID: 27109614
[TBL] [Abstract] [Full Text] [Related]
19. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.
de'Angelis N; Landi F; Carra MC; Azoulay D
World J Gastroenterol; 2015 Oct; 21(39):11185-98. PubMed ID: 26494973
[TBL] [Abstract] [Full Text] [Related]
20. Cooperation of DLC1 and cdk6 affects breast cancer clinical outcome.
Dai X; Li L; Liu X; Hu W; Yang Y; Bai Z
G3 (Bethesda); 2014 Nov; 5(1):81-91. PubMed ID: 25425654
[TBL] [Abstract] [Full Text] [Related]
[Next]